Cargando…

Longitudinal retinal layer changes in preclinical Alzheimer’s disease

PURPOSE: Several studies found reduced retinal thickness on optical coherence tomography (OCT) in Alzheimer’s disease (AD), even in preclinical stages, labelling this technique of interest as biomarker. In this study, we examine retinal thickness changes in preclinical AD, as defined by cognitively...

Descripción completa

Detalles Bibliográficos
Autores principales:	van de Kreeke, Jacoba A., Nguyen, Hoang Ton, Konijnenberg, Elles, Tomassen, Jori, den Braber, Anouk, ten Kate, Mara, Yaqub, Maqsood, van Berckel, Bart, Lammertsma, Adriaan A., Boomsma, Dorret I., Tan, H. Stevie, Visser, Pieter Jelle, Verbraak, Frank D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451744/ https://www.ncbi.nlm.nih.gov/pubmed/33073531 http://dx.doi.org/10.1111/aos.14640

Ejemplares similares

Optical coherence tomography angiography in preclinical Alzheimer’s disease
por: van de Kreeke, Jacoba Alida, et al.
Publicado: (2020)

Retinal layer thickness in preclinical Alzheimer's disease
por: van de Kreeke, Jacoba A., et al.
Publicado: (2019)

Onset of Preclinical Alzheimer Disease in Monozygotic Twins
por: Konijnenberg, Elles, et al.
Publicado: (2021)

Ocular biomarkers for cognitive impairment in nonagenarians; a prospective cross-sectional study
por: van de Kreeke, Jacoba A., et al.
Publicado: (2020)

The EMIF-AD PreclinAD study: study design and baseline cohort overview
por: Konijnenberg, Elles, et al.
Publicado: (2018)

Associations of Brain Pathology Cognitive and Physical Markers With Age in Cognitively Normal Individuals Aged 60–102 Years
por: Legdeur, Nienke, et al.
Publicado: (2019)

Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease
por: den Haan, Jurre, et al.
Publicado: (2019)

Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer’s disease polygenic risk score
por: Tomassen, Jori, et al.
Publicado: (2022)

Abnormal cerebrospinal fluid levels of amyloid and tau are associated with cognitive decline over time in cognitively normal older adults: A monozygotic twin study
por: Tomassen, Jori, et al.
Publicado: (2022)

Amyloid-driven disruption of default mode network connectivity in cognitively healthy individuals
por: Ingala, Silvia, et al.
Publicado: (2021)

Assessing Amyloid Pathology in Cognitively Normal Subjects Using (18)F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods
por: Collij, Lyduine E., et al.
Publicado: (2019)

White matter microstructure disruption in early stage amyloid pathology
por: Collij, Lyduine E., et al.
Publicado: (2021)

Genetic, vascular and amyloid components of cerebral blood flow in a preclinical population
por: Padrela, Beatriz E, et al.
Publicado: (2023)

Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?
por: den Haan, Jurre, et al.
Publicado: (2019)

Genetically identical twin-pair difference models support the amyloid cascade hypothesis
por: Coomans, Emma M, et al.
Publicado: (2023)

Semi-quantitative cerebral blood flow parameters derived from non-invasive [(15)O]H(2)O PET studies
por: Koopman, Thomas, et al.
Publicado: (2017)

Test-Retest Variability of Relative Tracer Delivery Rate as Measured by [(11)C]PiB
por: Heeman, Fiona, et al.
Publicado: (2021)

Cerebral rituximab uptake in multiple sclerosis: A (89)Zr-immunoPET pilot study
por: Hagens, Marloes HJ, et al.
Publicado: (2017)

Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies
por: Yaqub, Maqsood, et al.
Publicado: (2012)

Subretinal Fibrosis Detection Using Polarization Sensitive Optical Coherence Tomography
por: Gräfe, Maximilian G. O., et al.
Publicado: (2020)

The spatial relation of diabetic retinal neurodegeneration with diabetic retinopathy
por: van de Kreeke, Jacoba A., et al.
Publicado: (2020)

Test-retest variability of quantitative [(11)C]PIB studies in Alzheimer’s disease
por: Tolboom, Nelleke, et al.
Publicado: (2009)

Model selection criteria for dynamic brain PET studies
por: Golla, Sandeep S. V., et al.
Publicado: (2017)

[(11)C]PIB amyloid quantification: effect of reference region selection
por: Heeman, Fiona, et al.
Publicado: (2020)

Precision estimates of relative and absolute cerebral blood flow in Alzheimer’s disease and cognitively normal individuals
por: Heeman, Fiona, et al.
Publicado: (2022)

Plasma biomarkers predict amyloid pathology in cognitively normal monozygotic twins after 10 years
por: den Braber, Anouk, et al.
Publicado: (2023)

An exploratory clinical study of p38α kinase inhibition in Alzheimer's disease
por: Scheltens, Philip, et al.
Publicado: (2018)

Genetically identical twins show comparable tau PET load and spatial distribution
por: Coomans, Emma M, et al.
Publicado: (2022)

Retinal thickness correlates with parietal cortical atrophy in early-onset Alzheimer's disease and controls
por: den Haan, Jurre, et al.
Publicado: (2017)

Diagnostic impact of [(18)F]flutemetamol PET in early-onset dementia
por: Zwan, Marissa D., et al.
Publicado: (2017)

Evaluation of Tracer Kinetic Models for Analysis of [(18)F]FDDNP Studies
por: Yaqub, Maqsood, et al.
Publicado: (2009)

Performance of a [(18)F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies
por: Coomans, Emma M., et al.
Publicado: (2023)

Impact of [(18)F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology
por: Cheebsumon, Patsuree, et al.
Publicado: (2011)

Brain activation during cognitive planning in twins discordant or concordant for obsessive–compulsive symptoms
por: den Braber, Anouk, et al.
Publicado: (2010)

Multitracer model for staging cortical amyloid deposition using PET imaging
por: Collij, Lyduine E., et al.
Publicado: (2020)

Amyloid‐β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest‐old
por: Pelkmans, Wiesje, et al.
Publicado: (2021)

Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status
por: Babapour Mofrad, Rosha, et al.
Publicado: (2021)

Regional associations of white matter hyperintensities and early cortical amyloid pathology
por: Lorenzini, Luigi, et al.
Publicado: (2022)

Quantitative Assessment of Arthritis Activity in Rheumatoid Arthritis Patients Using [(11)C]DPA-713 Positron Emission Tomography
por: Yaqub, Maqsood, et al.
Publicado: (2020)

Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study
por: Legdeur, Nienke, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3162b71h77uphq3tseluln4uqd